Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Therapy of Vevye and Flarex for Dry Eye Disease
NCT07553455Phase 4Enrolling by invitation
- Sponsor
- Canyon City Eyecare
- Start
- Apr 2026
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine ophthalmic solution, fluorometholone in dry eye disease (DED), sponsored by Canyon City Eyecare. Started Apr 2026; status: enrolling by invitation.
02
Drugs
cyclosporine ophthalmic solutionfluorometholone
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT07553455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07553455.